Phenotypic tools may refine preclinical sarcomeric HCM diagnosis; leaves open effects on management and outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jil C. Tardiff (2017) studied Preclinical Sarcomeric Hypertrophic Cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: